Allina Health System

Minneapolis, Minnesota 55407

0 studies enrolling now · 4 studies all time

What they study most

Acute Myocardial Infarction, Breast Cancer, Breast Neoplasms, Breast Neoplasms, Hormone Receptor Positive/HER2 Negative, Breast Neoplasms, Triple-Negative, COVID, Gastroenteropancreatic Neuroendocrine Tumor, Lung Neuroendocrine Neoplasm, Neoplasms, Neuroendocrine Carcinoma, Neuroendocrine Tumors, Percutaneous Coronary Revascularization

Studies at this site

• Neuroendocrine Tumors - Patient Reported Outcomes — Running, not enrolling
• Evaluation in STEMI Patients Using FDY-5301 — Completed
• Study of Mavrilimumab (KPL-301) in Participants Hospitalized With Severe Corona Virus Disease 2019 (COVID-19) Pneumonia and Hyper-inflammation — Completed
• Study to Evaluate the Safety and Antitumor Activity of CX-2009 Monotherapy and in Combination With CX-072 in Advanced Breast Cancer — Completed